OBJECTIVE: A multi-center, open-labeled, prospective, observational study was conducted to evaluate the efficacy of fluoxetine on energy level over 8 weeks in a group of Korean patients with major depressive disorder. METHODS: Of 635 (Ed- to avoid having to say "Six hundred..") patients with major depressive disorder in 24 centers who were recruited to 8 weeks treatment with fluoxetine, 136 were terminated at initial session, leaving 499 patients to be included in the final analysis. They were predominantly female (59.5%), with a mean age of 45.7+/-15.9 years. At three visits to the clinic (weeks 0, 4 and 8), a record was made of Retardation Factor score of Hamilton Rating Scale for Depression (HD-RF), Lack of Energy score of Symptom Check List-90R (SCL-E), Energy score (QOL-E) and Fatigue score (QOL-F) of Quality of Life, and Visual Analogue Scale for Energy Level (VAS-E). RESULTS: The average dose of fluoxetine was 18.5+/-6.8mg/day for the first 4 weeks and 25.3+/-10.6 mg/day for the second 4 weeks. Of the patients, 85.4% in the first 4-week period and 86.8% in the second 4-week period took more than 85% of the prescribed medication. At least one of the concomitant anxiolytic drugs with fluoxetine was prescribed to 79.8% of the patients (alprazolam 47.9%, lorazepam 21.4%). The energy symptoms were significantly improved by fluoxetine over time, according to the analysis controlling the improvement effect of global depressive symptoms using repeated measures ANCOVA with the change of total HAM-D score as a covariate. Even comparing with the patients who took concomitant anti-anxiety medication, those who did not take concomitant anti-anxiety medication showed greater improvement of energy symptoms irrespective of the severity of baseline anxiety symptoms. CONCLUSION: These findings demonstrate that fluoxetine is effective in restoring the energy of patients with major depressive disorder. They also suggest that physicians should be careful in prescribing sedating antidepressants or concomitant anti-anxiety medication with fluoxetine for patients with major depressive disorder.
Antidepressive Agents ; Anxiety ; Depression ; Depressive Disorder, Major* ; Fatigue ; Female ; Fluoxetine* ; Humans ; Lorazepam ; Observational Study* ; Prospective Studies ; Quality of Life

BACKGROUND: The in-hospital 'Utstein style' is international recommended guidelines for reporting outcome data from in-hospital resuscitation events. This study was designed to evaluate the current status of in-hospital cardiopulmonary resuscitation(CPR), and to provide basic data far the unified reporting guideline of resuscitation in Korea. METHODS: The patients who had received CPR in a university hospital were searched during one year period from March 1997. The variables according to the Utstein style were evaluated with review of the medical records. RESULTS: During the period, 428 patients had received CPR. Excluding the patients of out-of-hospital arrest and less than 8 years, 242 were enrolled. Their initial ECG rhythms were 55 of asystole, 148 of pulseless electrical activity, and 39 of ventricular fibrillation, The spontaneous circulation was returned in 118(49%, and 48(20% were maintained more than 24 hours. Twenty-two patients(9%) were discharged with spontaneous respiration. Among the survivors, 17 had the Cerebral Performance Category of 1. CONCLUSION: We recommend the Utstein style to report the outcome of in-hospital CPR.
Cardiopulmonary Resuscitation ; Electrocardiography ; Heart Arrest* ; Humans ; Korea ; Medical Records ; Respiration ; Resuscitation ; Survivors ; Ventricular Fibrillation

OBJECTIVES: This study is to examine the efficacy and the limitation of translated Korean version of the Obsessive-compulsive Drinking Scale. The Korean version of the scale is to be used for treatment and research on alcoholism. METHODS: This study was carried out to examine reliability and validity of the translated Korean version of the Obsessive-compulsive Drinking Scale. One hundred forty two out-patient alcohol dependence subjects were measured of their cognitive and behavioral aspects of craving with this scale. RESULTS: For 142 tested alcoholic subjects, internal consistency among 14 items of the Obsessive-compulsive Drinking Scale was 0.8947(Crohnbach's alpha). For 40 detoxified alcoholics, test-retest reliability of total score of the Korean version of the Obsessive-compulsive Drinking Scale was 0.76 (correlation coefficient, p<0.01). In 131 alcoholic subjects, validity of total score of the Korean version of the Obsessive-compulsive Drinking Scale was examined by correlation analysis with visual analogue scale (VAS). Correlation coefficient was 0.52 with VAS. Especially, correlation coefficient of compulsive subscale of the Korean version of the Obsessive-compulsive Drinking Scale was 0.61 with VAS. The total score of the Korean version of the Obsessive-compulsive Drinking Scale which was analyzed by repeated measure analyses of variance during 8 weeks was significantly different between the relapse group and the abstinence group. CONCLUSION: The Korean version of the Obsessive-compulsive Drinking Scale shows very similar psychometric performance to the original Obsessive-compulsive Drinking Scale developed by Anton. The Korean version, therefore, is an useful instrument that reflects characteristic drinking behaviors of alcoholics.
Alcoholics ; Alcoholism* ; Drinking Behavior ; Drinking* ; Humans ; Outpatients* ; Psychometrics ; Recurrence ; Reproducibility of Results*

BACKGROUND: Paraquat(PQ) is used widely all over the world for its excellent effect as a herbicide. But its mortality rate is known to be very high, because there is no effective therapeutic modality. Recently, surprising improvement in survival rate was reported using the cyclophosphamide & methylprednisolone pulse therapy in paraquat poisoning. However, this report was not based upon animal study, we designed this experiment to confirm the therapeutic effect. METHODS: Under the halothane anesthesia, paraquat dichloride 40 mg/kg was injected intraperitoneally to 18 Sprague-Dawley rats. Two hours later, cyclophsphamide 40 mg/kg IP and methylprednisolone 62.5 mg/kg IM were injected in the treatment group(n=9). After 24 hours, we examined serum creatinine levels and pathologic findings of lung stained with hematoxylin-eosin and Masson's trichrome. And 72 hour mortality was compared between 2 groups(5 rats respectively). RESULTS: There were no statistical differences between the treatment group and control group in serum creatinine level, degree of lung injury, and survival rates. CONCLUSION: Cyclophosphamide and high dose methylprednisolone combination therapy did not decrease pulmonary toxicity and mortality of paraquat poisoned rats. Further animal studies using various doses and administrative methods of above medications are necessary to demonstrate their effects.
Anesthesia ; Animals ; Creatinine ; Cyclophosphamide* ; Halothane ; Lung ; Lung Injury ; Methylprednisolone* ; Mortality ; Paraquat* ; Poisoning ; Rats* ; Rats, Sprague-Dawley ; Survival Rate

No abstract available.
Catheters

No abstract available.
Humans ; Hypersensitivity* ; Phenytoin*

Plasmodium vivax is a typically seen infectious disease in Korea. The incidence of Plasmodium vivax malaria has been increasing in recent year despite of worldwide attempts at control. Fever, anemia, thrombocytopenia, and splenomegaly are the most common manifestations seen in Korean patient with P. vivax. Cardiac involvement is thought to be a very rare complication of malaria infection. Cardiac complication seems to be limited to acute infection with Plasmodium falcifarum. However we have experienced cardiac complication such as pericardial effusion, and complete AV block by Plasmodium vivax. Physicians should consider cardiac involvement in patient who present hypotension, fever and arrhythmia in malaria endemic area.
Anemia ; Arrhythmias, Cardiac* ; Atrioventricular Block ; Communicable Diseases ; Fever ; Humans ; Hypotension ; Incidence ; Korea ; Malaria ; Malaria, Vivax ; Pericardial Effusion* ; Plasmodium vivax* ; Plasmodium* ; Splenomegaly ; Thrombocytopenia

Plasmodium vivax is a typically seen infectious disease in Korea. The incidence of Plasmodium vivax malaria has been increasing in recent year despite of worldwide attempts at control. Fever, anemia, thrombocytopenia, and splenomegaly are the most common manifestations seen in Korean patient with P. vivax. Cardiac involvement is thought to be a very rare complication of malaria infection. Cardiac complication seems to be limited to acute infection with Plasmodium falcifarum. However we have experienced cardiac complication such as pericardial effusion, and complete AV block by Plasmodium vivax. Physicians should consider cardiac involvement in patient who present hypotension, fever and arrhythmia in malaria endemic area.
Anemia ; Arrhythmias, Cardiac* ; Atrioventricular Block ; Communicable Diseases ; Fever ; Humans ; Hypotension ; Incidence ; Korea ; Malaria ; Malaria, Vivax ; Pericardial Effusion* ; Plasmodium vivax* ; Plasmodium* ; Splenomegaly ; Thrombocytopenia

PURPOSE: Diabetic nephropathy is the most serious of complications in diabetes mellitus. Thiazolidinedione (TZD) is thought to ameliorate diabetic nephropathy; however, the mechanism underlying this effect has not been elucidated. We hypothesized that the vascular endothelial growth factor (VEGF) participates in the pathogenesis of diabetic nephropathy and that TZD may be beneficial for the treatment of diabetic nephropathy because of the effect it has on VEGF. MATERIALS AND METHODS: 23 Otsuka- Long-Evans-Tokushima-Fatty (OLETF) rats and eight control Long-Evans-Tokushima-Otsuka (LETO) rats were divided into the following four groups: LETO group, control OLETF group, pioglitazone treated group (10mg/kg/day), and rosiglitazone treated group (3mg/kg/day). RESULTS: A progressive increase in urinary protein excretion was observed in the diabetic rats. Glomerular VEGF expression in the control OLETF rats was significantly higher than in the control LETO rats. However, there was a significant reduction in both the glomerular VEGF expression and the VEGF mRNA levels after treatment with pioglitazone and rosiglitazone. The twenty-four hour urine protein levels were significantly decreased in both groups of the treated OLETF rats. CONCLUSION: These results suggest that TZD may have beneficial effects on diabetic nephropathy by reducing the VEGF expression.
Vascular Endothelial Growth Factor A/genetics ; Thiazolidinediones/*therapeutic use ; Rats, Long-Evans ; Rats ; Male ; Hypoglycemic Agents/therapeutic use ; Disease Models, Animal ; Diabetic Nephropathies/*drug therapy ; Diabetes Mellitus, Type 2/*drug therapy ; Animals

Malignant melanoma is a very rare disease in children. There is an increased risk for the development of malignant melanoma in patient with giant congenital melanocytic nevus. The manifestations of distant metastases in malignant melanoma commonly indicate a poor prognosis. First line treatment of malignant melanoma is excision, but when associated with giant congenital melanocytic nevus, excision is very difficult due to the site and the size of the lesions. However, malignant melanoma is not sensitive to chemotherapy, but a child is more sensitive than an adult. We report a case of unresectable childhood malignant melanoma associated with a giant congenital melanocytic nevus in a 3 year-old female treated with chemotherapy.
Adult ; Child* ; Child, Preschool ; Drug Therapy ; Female ; Humans ; Melanoma* ; Neoplasm Metastasis ; Nevus, Pigmented ; Prognosis ; Rare Diseases